C

Coya Therapeutics Inc
NASDAQ:COYA

Watchlist Manager
Coya Therapeutics Inc
NASDAQ:COYA
Watchlist
Price: 6.325 USD 1.69% Market Closed
Market Cap: 105.8m USD
Have any thoughts about
Coya Therapeutics Inc?
Write Note

Intrinsic Value

COYA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one COYA stock under the Base Case scenario is 6.416 USD. Compared to the current market price of 6.325 USD, Coya Therapeutics Inc is Undervalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

COYA Intrinsic Value
6.416 USD
Undervaluation 1%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case
Compare COYA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about COYA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Coya Therapeutics Inc

Provide an overview of the primary business activities
of Coya Therapeutics Inc.

What unique competitive advantages
does Coya Therapeutics Inc hold over its rivals?

What risks and challenges
does Coya Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Coya Therapeutics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Coya Therapeutics Inc.

Provide P/S
for Coya Therapeutics Inc.

Provide P/E
for Coya Therapeutics Inc.

Provide P/OCF
for Coya Therapeutics Inc.

Provide P/FCFE
for Coya Therapeutics Inc.

Provide P/B
for Coya Therapeutics Inc.

Provide EV/S
for Coya Therapeutics Inc.

Provide EV/GP
for Coya Therapeutics Inc.

Provide EV/EBITDA
for Coya Therapeutics Inc.

Provide EV/EBIT
for Coya Therapeutics Inc.

Provide EV/OCF
for Coya Therapeutics Inc.

Provide EV/FCFF
for Coya Therapeutics Inc.

Provide EV/IC
for Coya Therapeutics Inc.

Show me price targets
for Coya Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Coya Therapeutics Inc?

How accurate were the past Revenue estimates
for Coya Therapeutics Inc?

What are the Net Income projections
for Coya Therapeutics Inc?

How accurate were the past Net Income estimates
for Coya Therapeutics Inc?

What are the EPS projections
for Coya Therapeutics Inc?

How accurate were the past EPS estimates
for Coya Therapeutics Inc?

What are the EBIT projections
for Coya Therapeutics Inc?

How accurate were the past EBIT estimates
for Coya Therapeutics Inc?

Compare the revenue forecasts
for Coya Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Coya Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Coya Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Coya Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Coya Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Coya Therapeutics Inc with its peers.

Analyze the financial leverage
of Coya Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Coya Therapeutics Inc.

Provide ROE
for Coya Therapeutics Inc.

Provide ROA
for Coya Therapeutics Inc.

Provide ROIC
for Coya Therapeutics Inc.

Provide ROCE
for Coya Therapeutics Inc.

Provide Gross Margin
for Coya Therapeutics Inc.

Provide Operating Margin
for Coya Therapeutics Inc.

Provide Net Margin
for Coya Therapeutics Inc.

Provide FCF Margin
for Coya Therapeutics Inc.

Show all solvency ratios
for Coya Therapeutics Inc.

Provide D/E Ratio
for Coya Therapeutics Inc.

Provide D/A Ratio
for Coya Therapeutics Inc.

Provide Interest Coverage Ratio
for Coya Therapeutics Inc.

Provide Altman Z-Score Ratio
for Coya Therapeutics Inc.

Provide Quick Ratio
for Coya Therapeutics Inc.

Provide Current Ratio
for Coya Therapeutics Inc.

Provide Cash Ratio
for Coya Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Coya Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Coya Therapeutics Inc?

What is the current Free Cash Flow
of Coya Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Coya Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Coya Therapeutics Inc

Current Assets 38.4m
Cash & Short-Term Investments 35.5m
Other Current Assets 2.8m
Non-Current Assets 31.7k
PP&E 31.8k
Other Non-Current Assets -100
Current Liabilities 4.3m
Accounts Payable 1.7m
Accrued Liabilities 1.8m
Other Current Liabilities 841.4k
Non-Current Liabilities 694.4k
Other Non-Current Liabilities 694.4k
Efficiency

Free Cash Flow Analysis
Coya Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Coya Therapeutics Inc

Revenue
3.7m USD
Operating Expenses
-23.1m USD
Operating Income
-19.4m USD
Other Expenses
2.3m USD
Net Income
-17.1m USD
Fundamental Scores

COYA Profitability Score
Profitability Due Diligence

Coya Therapeutics Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
14/100
Profitability
Score

Coya Therapeutics Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

COYA Solvency Score
Solvency Due Diligence

Coya Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Coya Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COYA Price Targets Summary
Coya Therapeutics Inc

Wall Street analysts forecast COYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COYA is 17.51 USD with a low forecast of 15.655 USD and a high forecast of 18.9 USD.

Lowest
Price Target
15.655 USD
148% Upside
Average
Price Target
17.51 USD
177% Upside
Highest
Price Target
18.9 USD
199% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Coya Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for COYA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

COYA Insider Trading
Buy and sell transactions by insiders

COYA News

Other Videos
What is the Intrinsic Value of one COYA stock?

The intrinsic value of one COYA stock under the Base Case scenario is 6.416 USD.

Is COYA stock undervalued or overvalued?

Compared to the current market price of 6.325 USD, Coya Therapeutics Inc is Undervalued by 1%.

Back to Top